US equities
|
SPCX
$166.91
▲+5.00%
NVDA
$236.54
▲+1.11%
MU
$1,063.44
▼-1.07%
TSLA
$377.82
▲+1.95%
MSFT
$526.64
▲+1.76%
SNDK
$1,714.10
▼-0.34%
INTC
$116.73
▼-2.18%
META
$745.32
▲+2.37%
SPCX
$166.91
▲+5.00%
NVDA
$236.54
▲+1.11%
MU
$1,063.44
▼-1.07%
TSLA
$377.82
▲+1.95%
MSFT
$526.64
▲+1.76%
SNDK
$1,714.10
▼-0.34%
INTC
$116.73
▼-2.18%
META
$745.32
▲+2.37%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Kyverna Therapeutics, Inc. - Common Stock
(NQ:
KYTX
)
6.230
+0.010 (+0.16%)
Delayed Quote
Updated: 11:27 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kyverna Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Kessler Topaz Meltzer & Check, LLP Notifies Kyverna Therapeutics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
January 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Initial Public Offering
Lawsuit
Kessler Topaz Meltzer & Check, LLP Notifies Kyverna Therapeutics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
January 10, 2025
RADNOR, PA - January 10, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kyverna...
Via
TheNewswire.com
Topics
Fraud
Initial Public Offering
Lawsuit
Kirby McInerney LLP Urges Investors in Kyverna Therapeutics, Inc. to Inquire About Their Rights in Class Action Lawsuit
January 10, 2025
From
Kirby McInerney LLP
Via
Business Wire
KYTX Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Kyverna Therapeutics, Inc. Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
January 08, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Initial Public Offering
Lawsuit
KYTX Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Kyverna Therapeutics, Inc. Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
January 08, 2025
RADNOR, PA - January 8, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kyverna...
Via
TheNewswire.com
Topics
Fraud
Initial Public Offering
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kyverna, Sun Communities, Cassava, and MGPI and Encourages Investors to Contact the Firm
January 07, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
January 07, 2025
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
January 05, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
January 05, 2025
RADNOR, PA - (NewMediaWire) - January 5, 2025 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kyverna...
Via
TheNewswire.com
Topics
Lawsuit
Kessler Topaz Meltzer & Check, LLP Reminds KYTX Investors of February 7, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm
January 02, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX
January 01, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Encourages Kyverna Therapeutics, Inc. Investors With Losses to Contact the Firm
December 30, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
December 30, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
December 27, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Faruqi & Faruqi Reminds Kyverna Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 – KYTX
December 26, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Kessler Topaz Meltzer & Check, LLP - Class Action Announcement for Kyverna Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Kyverna Therapeutics, Inc.
December 26, 2024
From
Kessler Topaz Meltzer & Check LLP
Via
GlobeNewswire
Investor Reminder (KYTX): Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of February 7, 2025 Deadline
December 24, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
KYVERNA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. and Encourages Investors to Contact the Firm
December 23, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
KYTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
December 23, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
December 23, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
KYTX Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Securities Fraud Class Action Lawsuit Deadline
December 22, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Initial Public Offering
Lawsuit
CLASS ACTION NOTICE FOR KYTX: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Contact the Firm
December 20, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Initial Public Offering
Lawsuit
CLASS ACTION NOTICE FOR KYTX: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Contact the Firm
December 20, 2024
RADNOR, PA - (NewMediaWire) - December 20, 2024 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against...
Via
TheNewswire.com
Topics
Fraud
Initial Public Offering
Lawsuit
KYTX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
December 20, 2024
From
Kessler Topaz Meltzer & Check LLP
Via
GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
December 20, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)
December 19, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
KYTX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc.
December 18, 2024
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)
December 18, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
December 18, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
KYVERNA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. and Encourages Investors to Contact the Firm
December 17, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
